ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 148.66

Change

+0.50 (+0.34)%

Market Cap

USD 1.10B

Volume

0.31M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

+0.86 (+1.11%)

USD 7.27B
OPCH Option Care Health Inc

+0.20 (+0.63%)

USD 5.55B
SGRY Surgery Partners Inc

+1.04 (+3.47%)

USD 3.93B
AMED Amedisys Inc

+0.11 (+0.11%)

USD 3.17B
LFST Lifestance Health Group Inc

+0.04 (+0.58%)

USD 2.67B
ASTH Astrana Health Inc

+2.80 (+5.42%)

USD 2.49B
ADUS Addus HomeCare Corporation

+1.73 (+1.35%)

USD 2.36B
AVAH Aveanna Healthcare Holdings In..

+0.16 (+3.06%)

USD 1.01B
HCSG Healthcare Services Group Inc

+0.53 (+5.00%)

USD 0.79B
CCRN Cross Country Healthcare Inc

+0.65 (+4.81%)

USD 0.51B

ETFs Containing ENSG

XSMO Invesco S&P SmallCap Mome.. 2.11 % 0.39 %

+1.71 (+2.45%)

USD 1.18B
IJT iShares S&P Small-Cap 600.. 1.33 % 0.25 %

+3.23 (+2.45%)

USD 6.12B
ESIX SPDR S&P SmallCap 600 ESG.. 1.00 % 0.00 %

+0.73 (+2.45%)

USD 5.24M
OASC OneAscent Small Cap Core .. 0.97 % 0.00 %

+0.65 (+2.45%)

N/A
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.91 % 0.00 %

+1.15 (+2.45%)

USD 0.14B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.91 % 0.00 %

+0.95 (+2.45%)

USD 0.14B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
QVMS Invesco Exchange-Traded F.. 0.74 % 0.00 %

+0.67 (+2.45%)

USD 0.19B
ISP6:LSE iShares III Public Limite.. 0.67 % 0.00 %

+113.50 (+2.45%)

USD 1.87B
IJR iShares Core S&P Small-Ca.. 0.66 % 0.07 %

+2.90 (+2.45%)

USD 81.92B
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

N/A
IDP6:SW iShares S&P SmallCap 600 .. 0.60 % 0.00 %

+1.73 (+2.45%)

USD 1.90B
2B77:XETRA iShares Ageing Population.. 0.60 % 0.00 %

+0.10 (+2.45%)

USD 0.50B
VRTGX Vanguard Russell 2000 Gro.. 0.57 % 0.00 %

+9.19 (+2.45%)

USD 1.19B
RTWO:LSE L&G Russell 2000 US Small.. 0.55 % 0.00 %

+2.22 (+2.45%)

USD 0.13B
RTWP:LSE Legal & General UCITS ETF.. 0.55 % 0.00 %

+143.50 (+2.45%)

USD 0.13B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.55 % 0.00 %

+1.67 (+2.45%)

USD 0.09B
JPSE JPMorgan Diversified Retu.. 0.38 % 0.29 %

+1.17 (+2.45%)

USD 0.50B
RSSL Global X Funds 0.32 % 0.00 %

+2.07 (+2.45%)

N/A
DFAS Dimensional U.S. Small Ca.. 0.31 % 0.00 %

+1.45 (+2.45%)

USD 8.31B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+414.50 (+2.45%)

USD 1.31B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+7.05 (+2.45%)

USD 1.31B
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.28 % 0.00 %

+0.80 (+2.45%)

USD 3.11B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.28 % 0.00 %

+1.32 (+2.45%)

USD 3.09B
VRTIX Vanguard Russell 2000 Ind.. 0.28 % 0.00 %

+8.21 (+2.45%)

USD 10.02B
FNY First Trust Mid Cap Growt.. 0.00 % 0.70 %

+1.16 (+2.45%)

USD 0.35B
HDG ProShares Hedge Replicati.. 0.00 % 0.95 %

+0.20 (+2.45%)

USD 0.03B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

+6.71 (+2.45%)

N/A
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

+0.96 (+2.45%)

USD 0.20B
SPSM SPDR® Portfolio S&P 600 .. 0.00 % 0.06 %

+1.11 (+2.45%)

USD 11.12B
USVM VictoryShares US Small Mi.. 0.00 % 0.25 %

+1.88 (+2.45%)

USD 0.26B
OLD 0.00 % 0.50 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
SAA ProShares Ultra SmallCap6.. 0.00 % 0.95 %

+1.23 (+2.45%)

USD 0.03B
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

+1.84 (+2.45%)

N/A
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

+3.34 (+2.45%)

USD 0.41B
UWM ProShares Ultra Russell20.. 0.00 % 0.95 %

+1.90 (+2.45%)

USD 0.25B
VIOG Vanguard S&P Small-Cap 60.. 0.00 % 0.20 %

+2.81 (+2.45%)

USD 0.92B
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

+2.60 (+2.45%)

N/A
VTWG Vanguard Russell 2000 Gro.. 0.00 % 0.20 %

+4.84 (+2.45%)

USD 0.96B
VTWO Vanguard Russell 2000 Ind.. 0.00 % 0.15 %

+2.12 (+2.45%)

USD 9.91B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+1.71 (+2.45%)

USD 0.08B
XSLV Invesco S&P SmallCap Low .. 0.00 % 0.25 %

+0.91 (+2.45%)

USD 0.32B
IDP6:LSE iShares S&P Small Cap 600.. 0.00 % 0.00 %

+1.94 (+2.45%)

N/A
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

+1.43 (+2.45%)

N/A
ZSML:CA BMO S&P US Small Cap Inde.. 0.00 % 0.00 %

+0.79 (+2.45%)

N/A
SMLE 0.00 % 0.00 %

N/A

N/A
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

+0.06 (+2.45%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.48% 88% B+ 86% B+
Dividend Return 0.11% 100% F 2% F
Total Return 32.59% 88% B+ 86% B+
Trailing 12 Months  
Capital Gain 46.07% 88% B+ 88% B+
Dividend Return 0.23% 100% F 2% F
Total Return 46.31% 88% B+ 87% B+
Trailing 5 Years  
Capital Gain 197.92% 70% C- 91% A-
Dividend Return 2.18% 50% F 7% C-
Total Return 200.10% 80% B- 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 31.58% 75% C 85% B
Dividend Return 31.90% 75% C 85% B
Total Return 0.32% 50% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 39.08% 63% D 46% F
Risk Adjusted Return 81.63% 100% F 92% A
Market Capitalization 1.10B 100% F 92% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 47% 26%
Price/Book Ratio 5.07 14% 22%
Price / Cash Flow Ratio 22.47 18% 13%
Price/Free Cash Flow Ratio 25.87 18% 12%
Management Effectiveness  
Return on Equity 14.78% 100% 85%
Return on Invested Capital 12.65% 89% 82%
Return on Assets 4.03% 68% 83%
Debt to Equity Ratio 9.75% 67% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.